BioLife Solutions, Inc.BLFSNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Percentile
P71
Within normal range
vs 5Y Ago
-3.2x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
2025-9.74%-623.2%
20241.86%+103.1%
2023-59.64%+63.4%
2022-162.89%-1065.4%
2021-13.98%-553.8%
20203.08%+195.4%
2019-3.23%+97.4%
2018-124.92%-669.8%
2017-16.23%+81.8%
2016-89.40%-